title: Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients.
abstract: Defective T cell functions, including IL-2 production and proliferation, have been shown in SLE patients. After T cell stimulation (first signal), a costimulatory signal (second signal) is required to achieve complete T cell activation. Main costimulatory signals are provided to T cells by B7 antigens (CD80 and CD86, expressed on antigen-presenting cells (APC)) upon interaction with its receptor, the CD28 molecule expressed on T cells. The aim of this study was to investigate the role of CD28/B7 interactions in the impaired T cell responses of SLE patients. We show that stimulation of T cells with phytohaemagglutinin (PHA) in the presence, but not in the absence, of anti-CD28 MoAb or B7+ cells results in tyrosine phosphorylation of specific substrates, transcription of mRNA and production of IL-2 that is indistinguishable in SLE patients and healthy controls. Moreover, proliferation of costimulated T cells from SLE and controls was specifically abrogated by blocking the CD28/B7 interactions by means of addition to the culture of the CTLA4-Ig fusion protein. However, in most patients activated APC failed to up-regulate B7 molecules, giving rise to ineffective costimulatory signalling to T cells. These results indicate that the CD28/B7 costimulatory pathway is defective in SLE patients.
authors.affiliation: Unidad de Inmunología, Hospital Universitario Reina Sofia, Spain.
authors.forename: F J
authors.initials: FJ
authors.lastname: García-Cózar
authors.forename: I J
authors.initials: IJ
authors.lastname: Molina
authors.forename: M J
authors.initials: MJ
authors.lastname: Cuadrado
authors.forename: M
authors.initials: M
authors.lastname: Marubayashi
authors.forename: J
authors.initials: J
authors.lastname: Peña
authors.forename: M
authors.initials: M
authors.lastname: Santamaría
mesh_terms: D000069594:Abatacept; D000328:Adult; D000938:Antigen-Presenting Cells / Q000276:immunology; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000502:physiology; D018122:B7-1 Antigen / Q000276:immunology*; D018106:CD28 Antigens / Q000502:physiology*; D060908:CTLA-4 Antigen; D005260:Female; D015870:Gene Expression; D006801:Humans; D018796:Immunoconjugates; D007376:Interleukin-2 / Q000235:genetics; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D008213:Lymphocyte Activation; D012333:RNA, Messenger / Q000235:genetics; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D015703:Antigens, CD; D000943:Antigens, Differentiation; D018122:B7-1 Antigen; D018106:CD28 Antigens; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D018796:Immunoconjugates; D007376:Interleukin-2; D012333:RNA, Messenger; D000069594:Abatacept